VTGN: Vistagen Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 79.95
Enterprise Value ($M) 5.23
Book Value ($M) 81.12
Book Value / Share 2.81
Price / Book 0.99
NCAV ($M) 78.76
NCAV / Share 2.73
Price / NCAV 1.02

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 9.35
Current Ratio 9.35

Balance Sheet (mrq) ($M)
Current Assets 89.94
Assets 92.31
Liabilities 11.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A StemPoint Capital LP 8.20
02-14 13G/A Great Point Partners Llc 6.88 -24.69
02-14 13G/A Biotechnology Value Fund L P 9.97 11.06
11-14 13G/A Nantahala Capital Management, LLC 9.99 1.31
11-14 13G/A Citadel Advisors Llc 4.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-06-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-21 22,425 59,221 37.87
2025-03-20 107,279 203,186 52.80
2025-03-19 26,100 101,945 25.60
2025-03-18 26,351 109,357 24.10
2025-03-17 35,033 136,802 25.61

(click for more detail)

Similar Companies
VKTX – Viking Therapeutics, Inc. VRPX – Virpax Pharmaceuticals, Inc.
VSTM – Verastem, Inc. VTVT – vTv Therapeutics Inc.
VXRT – Vaxart, Inc.


Financial data and stock pages provided by
Fintel.io